Sagimet Biosciences (SGMT) Accounts Payables (2023 - 2024)
Historic Accounts Payables for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to $1.2 million.
- Sagimet Biosciences' Accounts Payables fell 3231.49% to $1.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.2 million, marking a year-over-year decrease of 3231.49%. This contributed to the annual value of $186000.0 for FY2023, which is N/A changed from last year.
- Per Sagimet Biosciences' latest filing, its Accounts Payables stood at $1.2 million for Q3 2024, which was down 3231.49% from $2.0 million recorded in Q2 2024.
- Sagimet Biosciences' Accounts Payables' 5-year high stood at $2.7 million during Q2 2023, with a 5-year trough of $186000.0 in Q4 2023.